Skip to main content

Advertisement

Table 1 Summary of studies and frequency table for original ordinal outcome in both studies

From: Predicting multi-level drug response with gene expression profile in multiple myeloma using hierarchical ordinal regression

Study Mulligan et al. [10] Terragna et al. [2]
Treatment Bortezomib VTD
Number of Samples 169 118
Number of Probes 22,283 54,677
Patients Population Relapsed MM New-Diagnosis
  Progressive Disease (PD) Stable Disease (SD)
  13 (7.70%) 7 (5.93%)
  No Change (NC) Partial Response (PR)
  60 (35.50%) 42 (35.59%)
  Minimal Response (MR) Very good partial response (VGPR)
  12 (7.10%) 40 (33.90%)
  Partial Response (PR) near Complete Response (nCR)
  43 (25.44%) 14 (11.87%)
  Complete Response (CR) Complete Response (CR)
  41 (24.26%) 15 (12.71%)